Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397]
Critical Care2006Vol. 10(3), pp. R96–R96
Citations Over TimeTop 10% of 2006 papers
Mirjam Christ‐Crain, Nils G. Morgenthaler, Daiana Stolz, Christian Müller, Roland Bingisser, Stephan Harbarth, Michael Tamm, Joachim Struck, Andreas Bergmann, Beat P. Müller‐Stich
Abstract
ProADM, as a novel biomarker, is a useful tool for the risk stratification of patients with CAP.
Related Papers
- → Community acquired pneumonia: assessment and treatment(2012)15 cited
- → THE STATE OF THE PROOXIDANT-ANTIOXIDANT BLOOD SYSTEM IN CHILDREN WITH COMMUNITY-ACQUIRED PNEUMONIA(2023)1 cited
- [Community-acquired pneumonia caused by biological pathogens].(2012)
- The Application of C-reactive Protein in Severe Community Acquired Pneumonia of Elderly Patients(2011)
- → Assement of Severity of Community Acquired Pneumonia By CURB-65(2019)